2021-01-08,"Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021"
2021-01-07,Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
2021-01-07,12 Best Telemedicine Stocks to Buy Now
2021-01-06,"Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics, Named to Modern Healthcare's 100 Most Influential People in Healthcare"
2021-01-05,Labcorp Is Scheduled to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-29,Hudson Technologies Applauds Adoption of Omnibus/Covid-19 Relief Which Includes the Phasedown of HFC Production
2020-12-27,Billionaire Larry Robbins Top 10 Stock Picks
2020-12-21,Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
2020-12-21,Walgreens and Labcorp Make Pixel by Labcorp At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®
2020-12-18,LabCorp (LH) Gains As Market Dips: What You Should Know
2020-12-17,What you need to know about at-home and over-the-counter COVID-19 tests
2020-12-16,Hedge Funds Have Never Been This Bullish On Cardiff Oncology (CRDF)
2020-12-15,Coronavirus update: FDA to weigh Moderna COVID-19 vaccine; new over the counter antigen test
2020-12-14,Implied Volatility Surging for Cardiff Oncology (CRDF) Stock Options
2020-12-11,LabCorp receives FDA authorization for at-home COVID-19 kits
2020-12-09,LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
2020-12-07,Is LH A Good Stock To Buy Now?
2020-12-06,Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
2020-12-01,"Some Cardiff Oncology, Inc. (NASDAQ:CRDF) Analysts Just Made A Major Cut To Next Year's Estimates"
2020-11-23,Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare Conference
2020-11-05,Hudson Technologies Reports Third Quarter 2020 Results
2020-11-05,Cardiff Oncology Announces Third Quarter 2020 Results and Highlights
2020-11-05,"Hudson Technologies, Inc. to Host Earnings Call"
2020-10-25,"Have Insiders Been Buying Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares?"
2020-10-22,Hudson Technologies to Host Conference Call to Discuss  Third Quarter 2020 Results
2020-10-20,Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance
2020-10-06,Hudson Technologies and Bluesource Partner to Reduce Greenhouse Gas Emissions Associated With HFC Refrigerants
2020-09-30,Cardiff Oncology Prices Public Offering
2020-09-29,Cardiff Oncology Announces Proposed Public Offering
2020-09-17,Cardiff Oncology Presents Data at ESMO Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)
2020-09-15,Cardiff Oncology to Host Key Opinion Leader Call Discussing KRAS-Mutated Colorectal Cancer and Highlighting Data from Onvansertib Phase 1b/2 Trial
2020-09-14,Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
2020-08-18,"What Kind Of Shareholders Hold The Majority In Cardiff Oncology, Inc.'s (NASDAQ:CRDF) Shares?"
2020-08-11,Cardiff Oncology Announces Second Quarter 2020 Results and Highlights
2020-08-04,Cardiff Oncology to Participate in Fireside Chat at the Virtual BTIG Biotechnology Conference
2020-07-30,Cardiff Oncology to Participate in the William Blair Biotech Focus Conference
2020-06-16,Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
2020-06-15,"Cardiff Oncology Data Continues to Demonstrate Efficacy, Durability and Safety of Onvansertib in Patients with Difficult-to-Treat Relapsed/Refractory AML"
2020-06-09,Cardiff Oncology Announces Expanded Access Program for Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer as Follow-On to Fast Track Designation
2020-05-29,Cardiff Oncology Data Continues to Demonstrate Efficacy of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer Presented at ASCO
2020-05-28,Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
2020-05-27,Cardiff Oncology Announces $2.5 Million Equity Investment by Biotech-Focused Fundamental Investor Acorn Bioventures
2020-05-19,Cardiff Oncology Announces Private Placement Investment by Board of Directors and Chief Executive Officer
2020-05-13,Cardiff Oncology Enters Agreement with PoC Capital to Fund Phase 2 Clinical Trial of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)
